Navigation Links
TB vaccine candidate shows early promise
Date:9/4/2011

September 4, 2011 ─ (BRONX, NY) ─ Researchers at Albert Einstein College of Medicine of Yeshiva University report in the September 4 online edition of Nature Medicine that they have developed a tuberculosis (TB) vaccine candidate that proved both potent and safe in animal studies. (http://www.who.int/mediacentre/factsheets/fs104/en/) According to the World Health Organization, TB kills an estimated 1.7 million people each year and infects one out of three people around the globe. With drug-resistant strains spreading, a vaccine for preventing TB is urgently needed.

"Producing effective TB vaccines requires a better understanding of the mechanisms used by Mycobacterium tuberculosis [the bacterial species that causes TB] to evade the body's immune responses," said senior author William Jacobs, Jr., Ph.D., professor of microbiology & immunology and of genetics at Einstein and a Howard Hughes Medical Institute investigator. He notes that the only currently used vaccine, the Bacille Calmette-Gurin (BCG) vaccine, has been notoriously inconsistent in protecting against TB.

To determine how M. tuberculosis outwits the immune response, Dr. Jacobs and his colleagues worked with a closely related species known as Mycobacterium smegmatis that is lethal to mice at high doses but does not harm people. The researchers created a version of M. smegmatis lacking a set of genes, known as ESX-3, considered crucial for evading host immunity. When high doses of the altered bacteria were infused into mice, it became clear that bacteria lacking the ESX-3genes could no longer evade their hosts' immune system: the mice controlled and cleared th
'/>"/>

Contact: Kim Newman
Sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Scripps Research scientists create vaccine against heroin high
2. Promising developments in vaccine research, development of a vaginal gel and PrEP lead to calls for a combination of biomedical and non biomedical approaches to HIV prevention policy
3. Discovery of natural antibody brings a universal flu vaccine a step closer
4. Innovative vaccines with nanotechnology
5. Adjuvant combo shows potential for universal influenza vaccine
6. Study shows the HPV vaccine Gardasil doesnt increase disease activity in SLE patients
7. 2020 vision of vaccines for malaria, TB and HIV/AIDS
8. Vaccine protects from deadly Hendra virus
9. Celiac disease vaccine shows promising results in Phase I trial
10. Study identifies promising target for AIDS vaccine
11. HIV protein unveils vaccine target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2015)... , Feb. 12, 2015   MedNet ... specializing in clinical study management systems, has recently ... , further distinguishing iMedNet ... Research Organizations (CROs) and healthcare consultants.  Building on ... prospective customer referrals and numerous co-marketing opportunities), MedNet,s ...
(Date:2/9/2015)... 9, 2015  Lintec of America recently announced an ... nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed ... Leveraging the vast industrial resources of the global ... , Lintec of America is forming the Nano-Science and ... , focusing on scaling up the manufacturing and commercialization ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... website ( http://www.nxt-id.com/ ) as part of its 2015 ... The Company launched its new consumer website for Wocketwallet.com ... , CEO of NXT-ID said, "Our new corporate website ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... two genes that control electrical excitability in a portion ... insomnia disorder in mice, UT Southwestern Medical Center researchers ... the disorder and provide an animal model for developing ... dramatic sleep-disturbance mutations, said Dr. Rolf Joho, associate professor ...
... received a five-year, $11.6 million grant from the National ... of cardiac injury that lead to heart failure and ... heart. This project aims to find data that can ... failing heart. This study is unique ...
... the increase. From food packaging to the air we ... affecting our health and our fertility. Researchers ... part in one of the first studies of the ... the Reproductive Effects of Environmental Chemicals in Females Consortium ...
Cached Biology News:Gene mutations in mice mimic human-like sleep disorder, UT Southwestern researchers find 2Jefferson receives $11.6M NIH grant to study novel mechanisms of heart failure 2Jefferson receives $11.6M NIH grant to study novel mechanisms of heart failure 3Do chemicals in the environment affect fertility? 2
(Date:3/6/2015)... , March 6, 2015   Senomyx , ... using proprietary taste science technologies to discover, develop, and ... flavor industries, announced today that John Poyhonen , the ... Rogers , Senior Vice President and Chief Financial Officer, ... currently scheduled for Wednesday, March 11, at 2:00 p.m. ...
(Date:3/5/2015)... , March 5, 2015  DuPont (NYSE: ... Transportation and Industrials Conference held today in ... Matthew L. Trerotola discussed strategy, progress and plans ... for DuPont.  Strengthening and growing the company,s leading position ... areas of strategic priority for DuPont. Discussing ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 BioPlus Specialty ... the position of Vice President of Managed Care. In ... relationships for one of the nation’s leading specialty pharmacies. ... than 15 years of specialty pharmacy and biotech experience ... with Raptor Pharmaceuticals, Vertex Pharmaceuticals, and Pfizer. Prior to ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ) has ... 2015: New Therapy Ventures Pave the Way for Success" ... biotech companies - Gilead (GILD), Amgen (AMGN), Biogen Idec ... a positive return and hence increased the interest of ... therapy/niche indication where the high treatment cost justifies the ...
Breaking Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE THE 27TH ANNUAL ROTH CONFERENCE 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 3DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 4BioPlus Specialty Pharmacy Announces Hiring of New Vice President of Managed Care: Jamie Damm 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3
... March 17, 2011 Advanced Life Sciences Holdings, Inc. (OTC ... will host a conference call and webcast discussing the Company,s ... 24, 2011 at 9:00 AM (EDT). Michael T. Flavin, Ph.D., ... of the management team, will also present an update on ...
... Delta Point, Inc., a consulting firm that specializes in ... Ed Weimer as Executive Account Director. Weimer has gained ... highly motivate, develop and inspire his teams to attain ... to the organization,s goals. Delta Point CEO ...
... March 17, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: ... developer, manufacturer and distributor of probiotics products in China, ... of strain formula supplied to Bright Dairy. ... that it supplies to Bright Dairy, one of the ...
Cached Biology Technology:Advanced Life Sciences to Host 2010 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast 2Ed Weimer Joins Delta Point, Inc. as Executive Account Director 2China-Biotics Expands Product Supplied to Bright Dairy 2China-Biotics Expands Product Supplied to Bright Dairy 3
Rabbit polyclonal to Aortic Elastin ( Abpromise for all tested applications). entrezGeneID: 2006 SwissProtID: P15502...
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
Mouse monoclonal [2A4] to Cytokeratin 8 + 18 + 19 ( Abpromise for all tested applications). Antigen: Cytokeratins isolated from cultured pig kidney epithelial cells. Entrez GeneID: 3856 S...
Feline Rhinotracheitis Virus...
Biology Products: